Heliogen, Inc.
HLGN
$0.85
-$0.05-5.56%
| Weiss Ratings | HLGN - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Very Weak | |||
| Risk Index | Weak | |||
| Risk Grade | D- | |||
| Reward Grade | E | |||
| Rating Factors | HLGN - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Weak | |||
| Efficiency Index | Very Weak | |||
| Solvency Index | Fair | |||
| Total Return Index | Very Weak | |||
| Volatility Index | Weak | |||
| Beta / Standard Deviation | HLGN - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 0.55 | |||
| Price History | HLGN - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | -19.81% | |||
| 30-Day Total Return | -25.44% | |||
| 60-Day Total Return | -57.50% | |||
| 90-Day Total Return | -31.45% | |||
| Year to Date Total Return | -51.15% | |||
| 1-Year Total Return | -44.08% | |||
| 2-Year Total Return | -91.46% | |||
| 3-Year Total Return | -99.51% | |||
| 5-Year Total Return | -- | |||
| 52-Week High % Change | -76.92% | |||
| 52-Week Low % Change | 5.88% | |||
| Price | HLGN - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $3.90 | |||
| 52-Week Low Price | $0.85 | |||
| 52-Week Low Price (Date) | Mar 04, 2025 | |||
| 52-Week High Price (Date) | Jul 11, 2024 | |||
| Valuation | HLGN - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 5.49M | |||
| Enterprise Value | -32.23M | |||
| Price/Earnings (TTM) | -- | |||
| Earnings Per Share (TTM) | -20.82 | |||
| Earnings Per Share Growth | 37.74% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | 1.49 | |||
| Price/Book (Q) | -0.11 | |||
| Enterprise Value/Revenue (TTM) | -8.76 | |||
| Price | $0.85 | |||
| Enterprise Value/EBITDA (TTM) | 0.28 | |||
| Enterprise Value/EBIT | 0.27 | |||
| Market Cap Category | Nano Cap | |||
| Dividends and Shares | HLGN - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 6.09M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | HLGN - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 626 720 4530 | |||
| Address | 130 West Union Street Pasadena, CA 91103 | |||
| Website | www.heliogen.com | |||
| Country | United States | |||
| Year Founded | -- | |||
| Profitability | HLGN - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | -3,212.47% | |||
| Profit Margin | -3,400.08% | |||
| Management Effectiveness | HLGN - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | -76.21% | |||
| Return on Equity | -- | |||
| Income Statement | HLGN - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 3.68M | |||
| Total Revenue (TTM) | 3.68M | |||
| Revenue Per Share | $0.61 | |||
| Gross Profit (TTM) | -4.12M | |||
| EBITDA (TTM) | -116.90M | |||
| EBIT (TTM) | -118.22M | |||
| Net Income (TTM) | -125.12M | |||
| Net Income Avl. to Common (TTM) | -125.12M | |||
| Total Revenue Growth (Q YOY) | -53.81% | |||
| Earnings Growth (Q YOY) | 36.38% | |||
| EPS Diluted (TTM) | -20.82 | |||
| EPS Diluted Growth (Q YOY) | 37.98% | |||
| Balance Sheet | HLGN - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 44.63M | |||
| Cash Per Share (Q) | $7.33 | |||
| Total Current Assets (Q) | 48.76M | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | -51.59M | |||
| Current Ratio (Q) | 0.465 | |||
| Book Value Per Share (Q) | -$8.53 | |||
| Total Assets (Q) | 57.99M | |||
| Total Current Liabilities (Q) | 104.96M | |||
| Total Debt (Q) | 6.92M | |||
| Total Liabilities (Q) | 109.58M | |||
| Total Common Equity (Q) | -51.59M | |||
| Cash Flow | HLGN - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | 29.14M | |||
| Cash from Financing (TTM) | -62.00K | |||
| Net Change in Cash (TTM) | -18.76M | |||
| Levered Free Cash Flow (TTM) | -5.53M | |||
| Cash from Operations (TTM) | -47.83M | |||
